Success Metrics

Active Trials
1(50%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

2

all time

Status Distribution
Active(2)

Detailed Status

Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
1
Success Rate
N/A

Trials by Status

active_not_recruiting150%
not_yet_recruiting150%

Recent Activity

1 active trials
Showing 2 of 2
not_yet_recruiting

Targeting IRAK4 in Chronic Lymphocytic Leukemia

NCT07741695
active_not_recruiting

MRD in High-risk EBC

NCT06566729

Clinical Trials (2)

Showing 2 of 2 trials
NCT07741695

Targeting IRAK4 in Chronic Lymphocytic Leukemia

Not Yet Recruiting
NCT06566729

MRD in High-risk EBC

Active Not Recruiting

All 2 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
2